{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:46:17Z","timestamp":1757706377390},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T00:00:00Z","timestamp":1432080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12891-015-0580-8","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T20:33:48Z","timestamp":1432067628000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Huey-En","family":"Tzeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Muo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Te","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horng-Chang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hao","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,20]]},"reference":[{"issue":"6","key":"580_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","volume":"30","author":"B Ramaswamy","year":"2003","unstructured":"Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol. 2003;30(6):763\u201375.","journal-title":"Semin Oncol"},{"issue":"5","key":"580_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/archinte.165.5.552","volume":"165","author":"Z Chen","year":"2005","unstructured":"Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, et al. Fracture risk among breast cancer survivors: results from the Women\u2019s Health Initiative Observational Study. Arch Intern Med. 2005;165(5):552\u20138.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"580_CR3","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.3747\/co.2008.174","volume":"15","author":"MN Khan","year":"2008","unstructured":"Khan MN, Khan AA. Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol. 2008;15 Suppl 1:S30\u201340.","journal-title":"Curr Oncol"},{"issue":"8","key":"580_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/archinternmed.2011.121","volume":"171","author":"VL Jacoby","year":"2011","unstructured":"Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women\u2019s Health Initiative Observational Study. Arch Intern Med. 2011;171(8):760\u20138.","journal-title":"Arch Intern Med"},{"issue":"11","key":"580_CR5","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s00198-010-1493-x","volume":"22","author":"JM Neuner","year":"2011","unstructured":"Neuner JM, Yen TW, Sparapani RA, Laud PW, Nattinger AB. Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. Osteoporos Int. 2011;22(11):2847\u201355.","journal-title":"Osteoporos Int"},{"issue":"10","key":"580_CR6","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1007\/s00268-010-0683-1","volume":"34","author":"SP Leong","year":"2010","unstructured":"Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308\u201324.","journal-title":"World J Surg"},{"issue":"9","key":"580_CR7","doi-asserted-by":"publisher","first-page":"e75109","DOI":"10.1371\/journal.pone.0075109","volume":"8","author":"CH Tsai","year":"2013","unstructured":"Tsai CH, Muo CH, Tzeng HE, Tang CH, Hsu HC, Sung FC. Fracture in Asian women with breast cancer occurs at younger age. PLoS One. 2013;8(9):e75109.","journal-title":"PLoS One"},{"issue":"1","key":"580_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"TJ Powles","year":"1996","unstructured":"Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol. 1996;14(1):78\u201384.","journal-title":"J Clin Oncol"},{"issue":"3","key":"580_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF01806160","volume":"39","author":"B Kristensen","year":"1996","unstructured":"Kristensen B, Ejlertsen B, Mouridsen HT, Andersen KW, Lauritzen JB. Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat. 1996;39(3):321\u20136.","journal-title":"Breast Cancer Res Treat"},{"issue":"32","key":"580_CR10","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1200\/JCO.2007.15.7123","volume":"26","author":"AL Cooke","year":"2008","unstructured":"Cooke AL, Metge C, Lix L, Prior HJ, Leslie WD. Tamoxifen use and osteoporotic fracture risk: a population-based analysis. J Clin Oncol. 2008;26(32):5227\u201332.","journal-title":"J Clin Oncol"},{"issue":"13","key":"580_CR11","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1074\/jbc.M112.405456","volume":"288","author":"GL Galea","year":"2013","unstructured":"Galea GL, Meakin LB, Sugiyama T, Zebda N, Sunters A, Taipaleenmaki H, et al. Estrogen receptor alpha mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor beta. J Biol Chem. 2013;288(13):9035\u201348.","journal-title":"J Biol Chem"},{"issue":"3","key":"580_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF01811242","volume":"12","author":"RR Love","year":"1988","unstructured":"Love RR, Mazess RB, Tormey DC, Barden HS, Newcomb PA, Jordan VC. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat. 1988;12(3):297\u2013302.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"580_CR13","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/jgs.12269","volume":"61","author":"PA Pawloski","year":"2013","unstructured":"Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, et al. Fracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc. 2013;61(6):888\u201395.","journal-title":"J Am Geriatr Soc"},{"issue":"13","key":"580_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"RR Love","year":"1992","unstructured":"Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med. 1992;326(13):852\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"580_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ctrv.2007.04.005","volume":"33","author":"H Ding","year":"2007","unstructured":"Ding H, Field TS. Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen? Cancer Treat Rev. 2007;33(6):506\u201313.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"580_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.clinthera.2007.08.013","volume":"29","author":"M Jahanzeb","year":"2007","unstructured":"Jahanzeb M. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women. Clin Ther. 2007;29(8):1535\u201347.","journal-title":"Clin Ther"},{"issue":"2","key":"580_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1385\/MO:21:2:117","volume":"21","author":"J Zidan","year":"2004","unstructured":"Zidan J, Keidar Z, Basher W, Israel O. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer. Med Oncol. 2004;21(2):117\u201321.","journal-title":"Med Oncol"},{"issue":"5","key":"580_CR18","doi-asserted-by":"publisher","first-page":"e62614","DOI":"10.1371\/journal.pone.0062614","volume":"8","author":"AA John-Baptiste","year":"2013","unstructured":"John-Baptiste AA, Wu W, Rochon P, Anderson GM, Bell CM. A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer. PLoS One. 2013;8(5):e62614.","journal-title":"PLoS One"},{"issue":"6","key":"580_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/cncr.20492","volume":"101","author":"BE Hillner","year":"2004","unstructured":"Hillner BE. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer. Cancer. 2004;101(6):1311\u201322.","journal-title":"Cancer"},{"issue":"10","key":"580_CR20","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1046\/j.1532-5415.2002.50455.x","volume":"50","author":"CL Leibson","year":"2002","unstructured":"Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50(10):1644\u201350.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"580_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3810\/pgm.2004.10.1598","volume":"116","author":"NJ McCarthy","year":"2004","unstructured":"McCarthy NJ. Care of the breast cancer survivor: increased survival rates present a new set of challenges. Postgrad Med. 2004;116(4):39. -40, 42, 45-36.","journal-title":"Postgrad Med"},{"issue":"2","key":"580_CR22","first-page":"183","volume":"5","author":"S Sinawat","year":"2004","unstructured":"Sinawat S, Chiyabutra T. Increased risk of endometrial abnormalities in breast cancer patients taking tamoxifen: the need for gynaecologic surveillance. Asian Pac J Cancer Prev. 2004;5(2):183\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"580_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-014-3140-2","volume":"148","author":"TW Chen","year":"2014","unstructured":"Chen TW, Chen HM, Lin CH, Huang CS, Cheng AL, Lai MS, et al. No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen. Breast Cancer Res Treat. 2014;148(1):135\u201342.","journal-title":"Breast Cancer Res Treat"},{"issue":"17","key":"580_CR24","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1158\/1078-0432.CCR-06-0688","volume":"12","author":"ME Lippman","year":"2006","unstructured":"Lippman ME, Cummings SR, Disch DP, Mershon JL, Dowsett SA, Cauley JA, et al. Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk. Clin Cancer Res. 2006;12(17):5242\u20137.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"580_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/jnci\/djj011","volume":"98","author":"MS Beattie","year":"2006","unstructured":"Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst. 2006;98(2):110\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"580_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1001\/jama.287.2.216","volume":"287","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Duong T, Kenyon E, Cauley JA, Whitehead M, Krueger KA. Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA. 2002;287(2):216\u201320.","journal-title":"JAMA"},{"issue":"5","key":"580_CR27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/oxfordjournals.aje.a114451","volume":"124","author":"JA Cauley","year":"1986","unstructured":"Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH, Sashin D. The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol. 1986;124(5):752\u201361.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"580_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJM199702273360903","volume":"336","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med. 1997;336(9):611\u20137.","journal-title":"N Engl J Med"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-015-0580-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0580-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T13:21:02Z","timestamp":1630588862000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-015-0580-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1186\/s12891-015-0580-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,20]]},"assertion":[{"value":"3 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"123"}}